✦ LIBER ✦

Endothelin Antagonists may be a Treatment Option for Cardiac Syndrome X, or Not ?

✍ Scribed by Günay, Şeyda; Baran, İbrahim; Aydınlar, Ali; Serdar, Osman Akın; Güllülü, Sümeyye; Yeşilbursa, Dilek; Özdemir, Bülent; Kaderli, Aysel Aydın; Şentürk, Tunay; Sağ, Saim

Book ID: 122620906
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 100 KB
Volume: 62
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.08.604

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fragile X syndrome therapy: to respond o

Fragile X syndrome therapy: to respond or not to respond may be a matter of methylation

✍ MA Pouladi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

Macitentan, a dual endothelin receptor a

Macitentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, does not affect cardiac repolarization in healthy subjects

✍ Lindegger, Nicolas; Sidharta, Patricia N.; Reseski, Kathrin; Dingemanse, Jasper 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 874 KB